Cherry silver berry (Elaeagnus multiflora) extracts exert antiinflammatory effects by inhibiting COX-2 and Akt signals in HT-29 colon cancer cells
- 118 Downloads
In this study, the potential of cherry silver berry (Elaeagnus multiflora) as a cancer preventive agent through regulating inflammatory signals including cyclooxygenase-2 (COX-2) and Akt was examined. Cherry silver berry has reported to exert anti-oxidative, anti-inflammatory, and anti-proliferative effects. The extracts from seed and flesh of cherry silver berry were obtained, and analyzed COX-2 and Akt activities in cherry silver berry extract treated HT-29 colon cancer cells. The results showed that the treatment of seed extracts reduced cell viability at the concentrations above 1,600 mg/mL, effectively reduced COX-2 and p-Akt expression. In addition, the anti-inflammatory effects seemed to be related to cancer cell death. Both of seed and flesh extracts inhibited cell growth and induced apoptosis in HT-29 cells. These results suggest that extracts of cherry silver berry may contribute to suppressing cancer growth through its anti-inflammatory and anti-proliferative effects, and natural products used as oriental medicine have the possibility to control tumor cell growth.
KeywordsAkt cyclooxygenase-2 apoptosis colon cancer Elaeagnus multiflora
Unable to display preview. Download preview PDF.
- 3.Kim SA, Oh SI, Lee MS. Antioxidative and cytotoxic effects of solvent fractions from Elaeagnus multiflora. Korean J. Food Nutr. 2: 134–142 (2007)Google Scholar
- 4.Chang ZQ, Park SC, Oh BC, Lee YS, Shin SR, Kim NW. Antiplatelet aggregation and anti-inflammatory activity for extracts of Elaeagnus multiflora. Korean J. Med. Crop Sci. 14: 516–517 (2006)Google Scholar
- 5.Oh SI, Lee MS. Antioxidative and cytotoxic effects of ethanol extracts from Elaeagnus multiflora. Korean J. Food Nutr. 4: 403–409 (2008)Google Scholar
- 6.Breynaert C, Vermeire S, Rutgeerts P, Van Assche G. Dysplasia and colorectal cancer in inflammatory bowel disease: A result of inflammation or an intrinsic risk? Acta Gastro-Ent. Belg. 71: 367–372 (2008)Google Scholar
- 22.Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar-Uniyal M. The antiproliferative effect of quercetin in cancer cells is mediated via inhibition of the PI5K-Akt/PκB pathway. Anticancer Res. 26: 1177–1181 (2006)Google Scholar